<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03959696</url>
  </required_header>
  <id_info>
    <org_study_id>2018P002848</org_study_id>
    <secondary_id>CDR-2017C3-9270</secondary_id>
    <nct_id>NCT03959696</nct_id>
  </id_info>
  <brief_title>Promoting Informed Decisions About Cancer Screening in Older Adults</brief_title>
  <acronym>PRIMED</acronym>
  <official_title>Promoting Informed Decisions About Colorectal Cancer Screening in Older Adults (PRIMED Study): Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maine Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Newton-Wellesley Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North Shore Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to examine the impact of different interventions designed to help
      individualize colorectal cancer (CRC) screening decisions in adults aged 76-85. Clinicians
      will be assigned by chance to one of two arms. In the Intervention arm, clinician
      participants will complete a training course and will also be notified of patients in the
      target age group who are due for a discussion about CRC screening. In the Comparator arm,
      clinician participants will be notified of their patients in the target age group with an
      upcoming visit who are due for a discussion about CRC screening. The investigators expect
      that patients seen by clinicians in the intervention arm will report more involvement in the
      decision making process, be more knowledgeable about the risks and benefits of CRC screening,
      and will have better quality decisions. Further, the investigators expect that the physicians
      in the intervention arm will have greater confidence in and demonstrate more skills for
      conducting shared decision making conversations as compared to those in the control arm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will advance understanding of how to engage and inform older adults in decisions
      about whether to continue or stop colorectal cancer (CRC) screening. The study will randomly
      assign about 50 primary care clinicians from 5 different sites to one of two different arms.
      In the Intervention arm, clinician participants will complete a training course and will also
      be notified of patients aged 76-85 with an upcoming visit who are due for a discussion about
      CRC screening. In the Comparator arm, clinician participants will be notified of their
      patients in the target age group with an upcoming visit who are due for a discussion about
      CRC screening. The study staff will collect surveys from about 500 eligible patients of
      participating physicians shortly after their visit to determine the impact of the
      intervention on patient-reported measures including the amount of shared decision making,
      knowledge, and preferences for cancer screening. Study staff will follow patients to track
      colorectal cancer screening tests in the 12 months following the visit and will survey
      patients again at 12 months to examine any barriers to follow through with their preferred
      approach. The study will also assess physician's ability to demonstrate shared decision
      making skills for cancer screening decisions in simulated patient interactions. Caregivers,
      if identified by a patient participant, will also complete a short survey evaluating the
      visit.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">August 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two-arm, multi-site cluster randomized controlled trial.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Physician participants will not be blinded to the study arm. Patients will not be given any information on their physician's assigned arm. Statistician will be blinded to the assignment when analyzing the results.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Shared Decision Making Process (SDMP) Scale Score</measure>
    <time_frame>1 week after physician visit</time_frame>
    <description>The SDM score is generated from the patient responses to the SDM Process survey instrument. Total scores range from 0-4, with higher scores indicating more shared decision making.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients' Colorectal Cancer Screening Knowledge Score</measure>
    <time_frame>1 week after physician visit</time_frame>
    <description>Colorectal Cancer (CRC) Screening Knowledge will be assessed with multiple choice knowledge items adapted from the CRC Decision Quality Instrument. A total score from 0-100% will be calculated based on the number of correct answers, with higher scores indicating higher knowledge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Patients who received preferred approach to Colorectal Cancer Testing</measure>
    <time_frame>1 week after physician visit (preference); 12 months after physician visit (testing)</time_frame>
    <description>Colorectal Cancer Screening Preference assessed with 1 item adapted from the CRC Decision Quality Instrument will be compared with the screening approach followed (assessed via chart review and patient report) to determine the percentage of patients who received preferred approach to testing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician's shared decision making skills</measure>
    <time_frame>Baseline</time_frame>
    <description>The transcripts from the simulated patient interactions will be scored by two coders using Braddock's Informed Decision Making framework. Total scores range from 0-9 with higher scores indicating more shared decision making in the interaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colorectal cancer screening rates</measure>
    <time_frame>1 year</time_frame>
    <description>The investigators will use established, validated algorithms for calculating cancer screening rates for patients aged 76-85 from a combination of administrative, billing and clinical data. Data will be aggregated at the physician, practice, and network level to identify the annual rate or percentage of eligible patients up to date for screening during the historical control period and concurrent control observation period both for clinicians enrolled in the study and clinicians not enrolled in the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician satisfaction with the visit</measure>
    <time_frame>1 week post visit</time_frame>
    <description>The percentage of clinicians who report that they are extremely satisfied with the visit will be compared across arms.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Caregiver SDM Process Scale score</measure>
    <time_frame>1 week after physician visit</time_frame>
    <description>Caregivers will complete an adapted version of the SDM Process survey to provide different perspective on the conversation and involvement of the patient. A total score will range from 0-4, with higher scores indicating more shared decision making.</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinician attitude toward shared decision making</measure>
    <time_frame>Baseline</time_frame>
    <description>The investigators will use five items to assess clinicians' confidence in Shared Decision Making Skills and Barriers to SDM. A total confidence score (0-20) with higher scores indicating higher confidence and a barrier score (0-8) higher scores indicating more barriers will be calculated.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Colorectal Cancer Screening</condition>
  <arm_group>
    <arm_group_label>Notification only arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinician participants will be notified of their patients aged 76-85 with an upcoming visit who are due for colorectal cancer screening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training and Notification arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinician participants will be notified of their patients aged 76-85 with an upcoming visit who are due for colorectal cancer screening and will complete a two-hour shared decision making communication skills training course that includes case studies, interactive exercises, and lecture content.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Notification</intervention_name>
    <description>Clinicians will be notified of their patients aged 76-85 with an upcoming, non urgent visit who are due for colorectal cancer screening.</description>
    <arm_group_label>Notification only arm</arm_group_label>
    <arm_group_label>Training and Notification arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Training</intervention_name>
    <description>The 2-hour continuing medical education course in shared decision making, simulated patient interaction to practice skills, and monthly calls for a year to review difficult cases with clinical and shared decision making experts.</description>
    <arm_group_label>Training and Notification arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For Clinicians, eligibility will not be decided by sex, gender, or age

        Inclusion Criteria for clinicians:

          -  Primary Care Physician (MD or NP)

          -  Manages a panel of patients

          -  Has â‰¥20 potentially eligible patients (age 76-85 and due for colorectal cancer
             screening) in their panel

          -  Practices at participating site

        Exclusion Criteria for clinicians:

          -  Residents, medical students

          -  Does not manage panel of patients (e.g. urgent care clinician)

        Patients of participating clinicians will be enrolled to evaluate the impact of the
        interventions.

        Inclusion Criteria for patients:

          -  Adults, age 76-85 at the time of the scheduled visit

          -  Scheduled for non-urgent office visit with a participating clinician during the study
             period

          -  Due or overdue for colorectal cancer screening (e.g. never been screened, 1 year or
             less to follow-up interval indicated on previous test).

        Exclusion Criteria for patients:

          -  Prior diagnosis of colon or rectal cancer, inflammatory bowel disease or genetic
             disorder that raises CRC risk (e.g. hereditary non-polyposis CRC and familial
             adenomatous polyposis)

          -  Unable to consent for themselves (e.g. moderate to severe dementia or other major
             cognitive limitations)

          -  Unable to read or write in English or Spanish
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen R Sepucha, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leigh Simmons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Medical Center</name>
      <address>
        <city>Danvers</city>
        <state>Massachusetts</state>
        <zip>01923</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newton-Wellesley Hospital</name>
      <address>
        <city>Newton</city>
        <state>Massachusetts</state>
        <zip>02462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 1, 2019</study_first_submitted>
  <study_first_submitted_qc>May 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2019</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Karen Sepucha</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Shared Decision Making</keyword>
  <keyword>Patient Reported Outcomes</keyword>
  <keyword>Continuing Medical Education</keyword>
  <keyword>early detection of cancer</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>colorectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>To promote research replicability, transparency and future use of the data, de-identified data sets of the patient and clinician survey data will be created and will be available, by request, to outside researchers.
After the main manuscripts have been published, de-identified data sets will also be deposited in an open access service such as, ICPSR (https://www.icpsr.umich.edu/icpsrweb/). Before a dataset is made available for access, ICPSR completes a detailed review of all datasets to assess disclosure risk. If necessary, ICPSR modifies data to reduce disclosure risk or limits access to datasets for which modifying the data would substantially limit their utility or the risk of disclosure remains high. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Three months after the end of the funded grant period, the study materials and de-identified data will be available, by request, from the PI. Once data are placed on an open access service such as ICPSR they will be available indefinitely.</ipd_time_frame>
    <ipd_access_criteria>The PI will share a de-identified data set with outside investigators at no cost, according to approved Partners and Massachusetts General Hospital policies for data sharing. Investigators from other sites will be able to request the data and will be required to complete a data use agreement that ensures that all local Institutional Review Board requirements are met before using the data, that they will not attempt to identify any data in the dataset, and that they will not share the data set with anyone outside their project team.
On ICPSR, individuals must register and agree to ICPSR's Responsible Use statement prior to accessing datasets.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

